doi:10.3969/j.issn.1673-8640.2022.01.021

Abstract

CLC Number:

R446.11

Figures/Tables 3

References 9

[1]	VALDÉS L, ALVAREZ D, VALLE J M, et al. The etiology of pleural effusions in an area with high incidence of tuberculosis[J]. Chest, 1996, 109(1):158-162. DOI URL
[2]	VERMA A, ABISHEGANADEN J, LIGHT R W. Identifying malignant pleural effusion by a cancer ratio(serum LDH:pleural fluid ADA ratio)[J]. Lung, 2016, 194(1):147-153. DOI URL
[3]	VERMA A, DAGAONKAR R S, MARSHALL D, et al. Differentiating malignant from tubercular pleural effusion by cancer ratio plus(cancer ratio:pleural lymphocyte count)[J]. Can Respir J, 2016, 2016:7348239.
[4]	LEE S J, KIM H S, LEE S H, et al. Factors influencing pleural adenosine deaminase level in patients with tuberculous pleurisy[J]. Am J Med Sci, 2014, 348(5):362-365. DOI URL
[5]	陆晓芳, 宋珊珊, 孙婷婷, 等. Sysmex XN-9000型血细胞分析仪与牛鲍手工法在体液标本检测中的应用效果及对肿瘤细胞筛查敏感度分析[J]. 中国医药, 2019, 14(2):294-296.
[6]	董静肖, 崔世伟, 高远, 等. 高荧光强度细胞对浆膜腔积液诊断的价值[J]. 北京医学, 2018, 40(9):837-840.
[7]	罗丽贞, 刘春林, 吴清念, 等. Sysmex XE-5000血液分析仪体液模式筛查肿瘤细胞价值的评价[J]. 检验医学, 2014, 29(2):169-171.
[8]	WU W, ZHAO C, SHEN T, et al. The diagnostic ability of high-fluorescent cells combined with carcinoembryonic antigen for malignant pleural effusion[J]. Int J Lab Hematol, 2019, 41(4):509-512.
[9]	KORCZYŃSKI P, MIERZEJEWSKI M, KRENKE R, et al. Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions[J]. Pol Arch Intern Med, 2018, 128(6):354-361.

组别	例数	HF#/（个/μL）	HF%/%	血清LDH/胸腔积液ADA比值
良性组	156	18（5~74）	1.0（0.3~4.5）	11.29（3.93~19.57）
恶性组	120	127（46~288）^*	13.1（4.7~25.6）^*	20.24（14.17~32.18）^*

组别	例数	HF#/（个/μL）	HF%/%	血清LDH/胸腔积液ADA比值
良性组	156	18（5~74）	1.0（0.3~4.5）	11.29（3.93~19.57）
恶性组	120	127（46~288）^*	13.1（4.7~25.6）^*	20.24（14.17~32.18）^*

年龄	良性胸腔积液患者	恶性胸腔积液患者
<60岁	5.43（3.31~16.48）	20.59（15.94~39.80）^*
≥60 岁	14.23（8.40~20.90）	19.88（13.84~31.71）^*

年龄	良性胸腔积液患者	恶性胸腔积液患者
<60岁	5.43（3.31~16.48）	20.59（15.94~39.80）^*
≥60 岁	14.23（8.40~20.90）	19.88（13.84~31.71）^*

[1]	DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090.
[2]	LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097.
[3]	. [J]. Laboratory Medicine, 2023, 38(11): 1098-1100.
[4]	. [J]. Laboratory Medicine, 2023, 38(10): 983-986.
[5]	. [J]. Laboratory Medicine, 2023, 38(9): 901-904.
[6]	. [J]. Laboratory Medicine, 2023, 38(9): 905-908.
[7]	CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859.
[8]	LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864.
[9]	DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674.
[10]	XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478.
[11]	CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis，activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483.
[12]	YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488.
[13]	. [J]. Laboratory Medicine, 2023, 38(5): 502-504.
[14]	. [J]. Laboratory Medicine, 2023, 38(1): 69-72.
[15]	XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 9

Related Articles 15

Recommended Articles

Metrics